MoonLake Immunotherapeutics (MLTX)
52.17
+0.29
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
52.27
+0.10
(+0.19%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Assets (Quarterly): 518.21M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 103.52B |
| AC Immune SA | 290.33M |
| CRISPR Therapeutics AG | 2.256B |
| Addex Therapeutics Ltd | 14.46M |
| NLS Pharmaceutics Ltd | 1.194M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.71M |
| Shareholders Equity (Quarterly) | 488.20M |